We are hiring! We are looking for a Lead Computational Chemist/Molecular Modeller at Pangea Bio, in either #Berlin or #London, hybrid mode. Click here to learn more and apply: https://lnkd.in/eAxWuFSr #PangeaBio #Startup #Biotech #AI #DrugDiscovery #ComputationalChemistry #DrugDevelopment
About us
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.
- Website
-
pangeabio.com
External link for Pangea Bio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
London, GB
Employees at Pangea Bio
Updates
-
Our colleague Dr. Fabien Schultz will be attending the 23rd International Congress of the International Society for Ethnopharmacology and the 2nd International Congress of the African Phytomedicine Scientific Society (ISE-APSS2024), hosted by the University of Pretoria from October 23-26, 2024, at the Cape Town International Convention Centre, South Africa! This is a fantastic opportunity to engage with experts in the field, share insights, and explore the latest developments in ethnopharmacology and phytomedicine. If you’re also attending and would like to connect with Fabien, feel free to reach out at [email protected] Learn more about the conference: https://lnkd.in/eD--eJcj #Ethnopharmacology #Networking #PangeaBio #DrugDevelopment #DrugDiscovery #NaturalProducts #ISEAPSS2024 #CapeTown #SouthAfrica
-
We are looking for a Cheminformatics Intern/Working Student to join our AI team in Berlin from January 2025 (with flexibility for hybrid working)! Our AI engine, PangeAI, enables us to explore the therapeutic potential of novel bioactive chemistry from the natural world at scale. With our technology we can select therapeutically relevant species, decode their chemical composition, and predict potential activity in the human body. This is an opportunity to join a fast-paced entrepreneurial environment, where you will have a significant influence on company decisions and performance. Click here to apply: https://lnkd.in/eZurN3jg #Team #Internship #DrugDiscovery #DrugDevelopment #AI #Cheminformatics #Startup
-
We are thrilled to announce that leading ethnopharmacologist Dr. Fabien Schultz has joined our team! With his extensive expertise and innovative approach to natural product discovery, Fabien will be instrumental in advancing our mission to unlock the potential of plants for drug discovery. Fabien is a distinguished ethnopharmacologist known for his groundbreaking research in natural product discovery and traditional medicine. His innovative work has led to the identification of several bioactive plants and plant-derived compounds with therapeutic potential, bridging the gap between indigenous knowledge and modern science. Fabien has published numerous influential papers, contributed to key advancements in pharmacological applications, and collaborated with diverse communities to promote sustainable practices in ethnobotany. His commitment to advancing the field has earned him recognition as a leader in ethnopharmacology. Welcome aboard, Fabien! Together, we’re excited to explore new frontiers in drug discovery and improve health outcomes for patients suffering from neurodegenerative diseases worldwide. Learn more: https://lnkd.in/e9Czcyz5 #TeamPangea #Ethnopharmacology #Ethnobotany #PangeaBio #DrugDiscovery #DrugDevelopment #NaturalProducts
-
We will be at the Lab of the Future Congress in Amsterdam today and tomorrow! Our President, AI Sona Chandra will be speaking at 1:45 CET today on how we harness AI to identify natural small-molecule therapeutics. She'll also be joining a panel to discuss insights and perspectives on the overall opportunity and space of AI in drug discovery together with James Malone (CTO, BenevolentAI) and Thrasyvoulos Karydis (CTO, DeepCure). Let us know if you will be at the conference and would like to meet up: [email protected] #PangeaBio #AI #DrugDiscovery #Biotech #Startup #LabOfTheFutureCongress
-
Our Chief Scientific Officer Alleyn Plowright is attending the 37th European College of Neuropsychopharmacology (ECNP) Congress in Milan today and tomorrow. He will present our poster ‘TrkB modulator OT-003 improves deficits in cognition and negative symptoms, and associated brain pathology in rat schizophrenia models’. Email us at [email protected] if you are also attending and would like to meet. #ECNP2024 #PangeaBio #DrugDevelopment #Schizophrenia #BrainHealth #Science
-
We will be attending the 7th Neuropsychiatric Drug Development Summit in Boston next week, from September 24-26th. This is a fantastic opportunity to engage with leaders in the field and discuss the latest advancements in neuropsychiatric research and drug development. If you’re attending and would like to connect with our Chief Scientific Officer, Alleyn Plowright, and our Co-Founder and Executive Director, R&D and Innovation Thomas Pfeiffer, please don’t hesitate to reach out. We are looking forward to an inspiring summit! Learn more here: https://lnkd.in/dVxKnyFF #PangeaBio #Neuropsychiatry #DrugDevelopment #Networking #Innovation #Boston
7th Neuropsychiatric Drug Development Summit
neuropsychiatric-drug-development.com
-
Earlier this week, our co-founder John Boghossian joined a panel discussion at The Monaco Private Label (MPL) event, an initiative by the Prince of Monaco's Government that unites global economic leaders. John participated in a thought-provoking session on "How Innovation Will Reshape Our Future and Unlock Longevity." He shared insights on the transformative potential of innovation in enhancing health and well-being, and how emerging computational methods can pave the way for a healthier future for all. John emphasized how at Pangea Bio it is our mission to tackle cognitive impairment associated with some of the most challenging and burdensome age-related diseases, including Alzheimer’s, dementia, schizophrenia, and Parkinson’s. He said: “My definition of "longevity" is increasing the quantity and the quality of time we can live — ensuring that people not only live longer but stay healthy and fulfilled throughout their lives. My drive and that of our team at Pangea Bio has been to work within the existing system to find treatments for age-related disorders and push them through clinical trials." A big thank you to the organizers around Chloé Leclercq and everyone involved for such an engaging event, and in particular to the other panel speakers Charles-Edouard Bouée, Bernardo Delarue Bizzini, Vincent Picco, André Loesekrug-Pietri⚡️ and Andrea Regina Garcia Mendez for the great moderation! We’re excited about the future and the role we can all play in driving innovation for longevity. #MonacoPrivateLabel #Innovation #Longevity #PangeaBio #DrugDevelopment #NaturalProducts
-
This week, our London and Berlin teams came together for an inspiring team meeting in our Berlin office! 🤝✨ It was fantastic to witness the energy within our team as we all met in person and delved into exciting strategy updates, had engaging discussions and enjoyed vibrant team-building activities. The energy and insights shared were truly invigorating and a testament to the strength of our team. A huge THANK YOU to everyone who participated and made this meeting so productive and enjoyable. 🙌 🚀 #PangeaBio #Startup #Teamwork #StrategyMeeting #Berlin #London #TeamSuccess
-
Pangea Bio is one of 13 techbio startups to watch - thanks for the shoutout Sifted! 👀 🙌 Here is the article: https://lnkd.in/eNMk22s6 #PangeaBio #Biotech #Startup #DrugDiscovery #AI #DrugDevelopment #MedicinalPlants
13 techbio startups to watch, according to investors
sifted.eu